Female sexual interest/arousal disorder: history of diagnostic considerations and their implications for clinical practice.
Witherow-Párkányi M.
Psychiatr Hung. 2022;37(2):133-149.
Female Sexual Dysfunction.
Reed MA.
Clin Plast Surg. 2022 Oct;49(4):495-504. doi: 10.1016/j.cps.2022.06.009. Epub 2022 Aug 17.
Female Sexual Dysfunction.
Clayton AH, Valladares Juarez EM.
Med Clin North Am. 2019 Jul;103(4):681-698. doi: 10.1016/j.mcna.2019.02.008.
The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M, Rahman F, Puri LI, Rubin RS.
Int J Impot Res. 2022 Nov;34(7):635-641. doi: 10.1038/s41443-022-00613-0. Epub 2022 Oct 5.
Female Sexual Dysfunction.
Clayton AH, Valladares Juarez EM.
Psychiatr Clin North Am. 2017 Jun;40(2):267-284. doi: 10.1016/j.psc.2017.01.004. Epub 2017 Mar 25.
Female sexual dysfunction.
Wright JJ, O'Connor KM.
Med Clin North Am. 2015 May;99(3):607-28. doi: 10.1016/j.mcna.2015.01.011. Epub 2015 Mar 6.
Topical alprostadil treatment of female sexual arousal disorder.
Kielbasa LA, Daniel KL.
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1369-76. doi: 10.1345/aph.1G472. Epub 2006 Jun 6.
The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr.
J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. doi: 10.1080/009262300278597.
Female sexual arousal disorders.
Giraldi A, Rellini AH, Pfaus J, Laan E.
J Sex Med. 2013 Jan;10(1):58-73. doi: 10.1111/j.1743-6109.2012.02820.x. Epub 2012 Sep 13.
Sildenafil citrate for female sexual arousal disorder: a future possibility?
Schoen C, Bachmann G.
Nat Rev Urol. 2009 Apr;6(4):216-22. doi: 10.1038/nrurol.2009.25.
